Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2013 1
2014 1
2021 4
2022 2
2023 2
2024 1
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen WJG, Rahbar K, Schoder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Kratochwil C, et al. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2830-2845. doi: 10.1007/s00259-023-06255-8. Epub 2023 May 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37246997 Free PMC article.
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial.
Kwan EM, Ng SWS, Tolmeijer SH, Emmett L, Sandhu S, Buteau JP, Iravani A, Joshua AM, Francis RJ, Subhash V, Lee ST, Scott AM, Martin AJ, Stockler MR, Donnellan G, Annala M, Herberts C, Davis ID, Hofman MS, Azad AA, Wyatt AW; TheraP Investigators and the ANZUP Cancer Trials Group. Kwan EM, et al. Nat Med. 2025 Aug;31(8):2722-2736. doi: 10.1038/s41591-025-03704-9. Epub 2025 May 27. Nat Med. 2025. PMID: 40425844 Clinical Trial.
Cytotoxicity properties of plant-mediated synthesized K-doped ZnO nanostructures.
Haghighat M, Alijani HQ, Ghasemi M, Khosravi S, Borhani F, Sharifi F, Iravani S, Najafi K, Khatami M. Haghighat M, et al. Bioprocess Biosyst Eng. 2022 Jan;45(1):97-105. doi: 10.1007/s00449-021-02643-2. Epub 2021 Sep 28. Bioprocess Biosyst Eng. 2022. PMID: 34581868
The cytotoxicity of these nanoparticles (NPs) on normal macrophage cells and cancer cell lines was evaluated. In the same concentrations of K-doped ZnO and pure ZnO NPs, K-doped ZnO NPs demonstrated higher toxicity. The results confirmed that the doped potassium cou …
The cytotoxicity of these nanoparticles (NPs) on normal macrophage cells and cancer cell lines was evaluated. In the same concentrations of …
Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy.
Pagani FD, Netuka I, Jorde UP, Katz JN, Gustafsson F, Connors JM, Uriel N, Soltesz EG, Ivak P, Bansal A, Bitar A, Vega JD, Goldstein D, Danter M, Pya Y, Ravichandran A, Conway J, Adler ED, Chung ES, Grinstein J, Dirckx N, Iravani B, Mehra MR. Pagani FD, et al. JACC Heart Fail. 2025 Jul;13(7):102411. doi: 10.1016/j.jchf.2025.01.017. Epub 2025 Apr 9. JACC Heart Fail. 2025. PMID: 40208135 Free article. Clinical Trial.
OBJECTIVES: This prespecified analysis of ARIES-HM3 studied clinical outcomes when concomitant surgical procedures are performed during LVAD implantation with excluding aspirin but maintaining a vitamin K antagonist. METHODS: Among 628 patients randomized to receive either …
OBJECTIVES: This prespecified analysis of ARIES-HM3 studied clinical outcomes when concomitant surgical procedures are performed during LVAD …
FDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab.
Iravani A, Wallace R, Lo SN, Galligan A, Weppler AM, Hicks RJ, Sandhu S. Iravani A, et al. Radiology. 2023 May;307(3):e221180. doi: 10.1148/radiol.221180. Epub 2023 Feb 28. Radiology. 2023. PMID: 36853183
Results In total, 122 patients (median age, 61 years [IQR, 51-69 years]; 89 men) were included; 78% (95 of 122) had an Eastern Cooperative Oncology Group score of 0, 52% (45 of 86) had an elevated lactate dehydrogenase level, 39% (48 of 122) had a metastatic stage of M1c and 45% …
Results In total, 122 patients (median age, 61 years [IQR, 51-69 years]; 89 men) were included; 78% (95 of 122) had an Eastern Cooperative O …
The selective 5-HT1A receptor agonist NLX-112 displays anxiolytic-like activity in mice.
Powell WH, Annett LE, Depoortere R, Newman-Tancredi A, Iravani MM. Powell WH, et al. Naunyn Schmiedebergs Arch Pharmacol. 2022 Feb;395(2):149-157. doi: 10.1007/s00210-021-02183-2. Epub 2021 Nov 25. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 34821958
Several studies have implicated 5-HT(1A) receptor activation in mitigating anxiety disorders, so this study investigated the acute effects of a highly selective, potent and efficacious 5-HT(1A) receptor full agonist, NLX-112 (a.k.a. befiradol, F13640), in middle-aged C57bl …
Several studies have implicated 5-HT(1A) receptor activation in mitigating anxiety disorders, so this study investigated the acute effects o …
Characteristics of Children With Kawasaki Disease-Like Signs in COVID-19 Pandemic: A Systematic Review.
Mardi P, Esmaeili M, Iravani P, Abdar ME, Pourrostami K, Qorbani M. Mardi P, et al. Front Pediatr. 2021 Mar 18;9:625377. doi: 10.3389/fped.2021.625377. eCollection 2021. Front Pediatr. 2021. PMID: 33816398 Free PMC article.
A comprehensive search was carried out systematically through PubMed, Scopus, and Web of Science (WoS), medRxiv, and bioRxiv by two reviewers independently for all studies or preprints data on the demographic, laboratory, and clinical characteristics of children with K.D-l …
A comprehensive search was carried out systematically through PubMed, Scopus, and Web of Science (WoS), medRxiv, and bioRxiv by two reviewer …
Diacylglycerol kinase η modulates oncogenic properties of lung cancer cells.
Nakano T, Iravani A, Kim M, Hozumi Y, Lohse M, Reichert E, Crotty TM, Stafforini DM, Topham MK. Nakano T, et al. Clin Transl Oncol. 2014 Jan;16(1):29-35. doi: 10.1007/s12094-013-1036-y. Epub 2013 Apr 10. Clin Transl Oncol. 2014. PMID: 23572183 Free PMC article.
METHODS: We determined the expression levels of DGKeta in a mouse models of mutant EGFR and K-Ras lung cancer and in human lung cancer cell lines with activating mutations in either EGFR or K-Ras. ...RESULTS: DGKeta was expressed in malignant epithelium from mice wi …
METHODS: We determined the expression levels of DGKeta in a mouse models of mutant EGFR and K-Ras lung cancer and in human lung cance …
15 results